Abstract:BackgroundVirtually all prostate cancer deaths occur due to obtaining the castration-resistant phenotype after prostate cancer cells escaped from apoptosis and/or growth suppression initially induced by androgen receptor blockade. TNF-related apoptosis-inducing ligand (TRAIL) was an attractive cancer therapeutic agent due to its minimal toxicity to normal cells and remarkable apoptotic activity in tumor cells. However, most localized cancers including prostate cancer are resistant to TRAIL-induced apoptosis, thereby creating a therapeutic challenge of inducing TRAIL sensitivity in cancer cells. Herein the effects of cyproterone acetate, an antiandrogen steroid, on the TRAIL-induced apoptosis of androgen receptor-negative prostate cancer cells are reported.MethodsCell apoptosis was assessed by both annexin V/propidium iodide labeling and poly (ADP-ribose) polymerase cleavage assays. Gene and protein expression changes were determined by quantitative real-time PCR and western blot assays. The effect of cyproterone acetate on gene promoter activity was determined by luciferase reporter assay.ResultsCyproterone acetate but not AR antagonist bicalutamide dramatically increased the susceptibility of androgen receptor-negative human prostate cancer PC-3 and DU145 cells to TRAIL-induced apoptosis but no effects on immortalized human prostate stromal PS30 cells and human embryonic kidney HEK293 cells. Further investigation of the TRAIL-induced apoptosis pathway revealed that cyproterone acetate exerted its effect by selectively increasing death receptor 5 (DR5) mRNA and protein expression. Cyproterone acetate treatment also increased DR5 gene promoter activity, which could be abolished by mutation of a consensus binding domain of transcription factor CCAAT-enhancer-binding protein homologous protein (CHOP) in the DR5 gene promoter. Cyproterone acetate increases CHOP expression in a concentration and time-dependent manner and endoplasmic reticulum stress reducer 4-phenylbutyrate could block cyproterone acetate-induced CHOP and DR5 up-regulation. More importantly, siRNA silencing of CHOP significantly reduced cyproterone acetate-induced DR5 up-regulation and TRAIL sensitivity in prostate cancer cells.ConclusionsOur study shows a novel effect of cyproterone acetate on apoptosis pathways in prostate cancer cells and raises the possibility that a combination of TRAIL with cyproterone acetate could be a promising strategy for treating castration-resistant prostate cancer.

Moleular mechanism of the apoptosis of prostate cancer cell line DU-145 cells induced by all trans retinoic acid

Molecular Mechanisms of Resistance to TRAIL-induced Apoptosis in Tumor

Effects of Different Chemotherapeutic Agents on Reversing the Acquired Resistance to TRAIL Gene in DLD1 Colon Cancer Cells

Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.

Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells.

[Effects of All-Trans Retinoic Acid on Expression of Connexin Genes and Gap Junction Communication in Hepatocellular Carcinoma Cell Lines].

Function of Retinoid Acid Receptor Α and P21 in All-Trans-retinoic Acid-Induced Acute T-lymphoblastic Leukemia Apoptosis

Effect of RARP gene transfection on apoptosis and survivin and caspase activities in gastric carcinonm cell line MKN - 45

Effect of RAR#beta# gene transfection on apoptosis and survivin and caspase activities in gastric carcinoma cell line MKN- 45

Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer

The expression of β-catenin in ovarian cancer cell line COC2 treated with all-trans-retinoic acid

Studies On The Apoptosis-Related Genes Of Tf-1 Cell Line By Cdna-Rda Technique.

Eukaryotic Expression and in Vitro Tumor Cell Apoptosis-induced Effect of Human TRAIL

[Action of Apoptosis-Induced Ligand Gene in Relation to Tumor Necrosis Factor on Human Colon Cancer Cell Line HT29].

Investigation of the Role of All-Trans Retinoid Acid in Inducing Differentiation of Retinoblastoma in Vivo

All-trans-retinoic Acid Increased the Expression of Integrin Alpha5beta1 and Induced "anoikis" in SMMC-7721 Hepatocarcinoma Cell.

Effect of All-Trans-retinoic Acid on Proliferation of Yolk Sac Tumor Cell Line and Expression of RAR- Β Gene in Inducing Differentiation in Vitro

Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5

All-trans Retinoic Acid Synergizes with Topotecan to Suppress AML Cells Via Promoting RARα-mediated DNA Damage

Effect Of Rar Beta Gene Transfection On Apoptosis And Survivin And Caspase Activities Of Gastric Carcinoma Cell Line Mkn-45

The effect of TRAIL combined with mitomycin C on apoptosis of human prostatic cancer cell DU145